MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Mast Therapeutics Company Profile (NASDAQ:MSTX)

Consensus Ratings for Mast Therapeutics (NASDAQ:MSTX) (?)
Ratings Breakdown: 2 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $6.50 (1,277.12% upside)

Analysts' Ratings History for Mast Therapeutics (NASDAQ:MSTX)
Show:
DateFirmActionRatingPrice TargetActions
6/9/2016Maxim GroupReiterated RatingBuy$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/9/2016Roth CapitalReiterated RatingBuy$8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/28/2014 forward)
Earnings History for Mast Therapeutics (NASDAQ:MSTX)
No earnings announcements for this company have been tracked by MarketBeat.com

Earnings Estimates for Mast Therapeutics (NASDAQ:MSTX)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividend History for Mast Therapeutics (NASDAQ:MSTX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Mast Therapeutics (NASDAQ:MSTX)
No insider trades for this company have been tracked by MarketBeat.com

Latest Headlines for Mast Therapeutics (NASDAQ:MSTX)
DateHeadline
05/21/16 01:05 PMBuzzers of Healthcare Sector: Medtronic plc (NYSE:MDT) , Mast Therapeutics, Inc. (NYSEMKT:MSTX) - Is stories - Buzzers of Healthcare Sector: Medtronic plc (NYSE:MDT) , Mast Therapeutics, Inc. (NYSEMKT:MSTX)Is storiesMast Therapeutics, Inc. (NYSEMKT:MSTX) started out trading at $0.3095 and hit to day high price of $0.3095 while it touched the day low price of $0.2850. Shares have gone down -1.6076% to close at $0.2999. The company shares changing hands with the ...
05/21/16 01:05 PMReview of Analysts Ranking: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) , Mast Therapeutics, Inc. (NYSEMKT:MSTX) - Street Updates - Review of Analysts Ranking: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) , Mast Therapeutics, Inc. (NYSEMKT:MSTX)Street UpdatesArena Pharmaceuticals, Inc. (NASDAQ:ARNA) accumulated +3.97%, closing at $1.57 after floating between $1.52 and $1.58. The company has market capitalization of $381.58M. It has twelve month low of $1.30 and twelve month high of $5.12. The recent ...and more »
05/17/16 12:56 PMHC Stocks Movements Activity: Inovio Pharmaceuticals Inc (NASDAQ:INO), Mast Therapeutics Inc (NYSEMKT:MSTX ... - share market updates (press release) - HC Stocks Movements Activity: Inovio Pharmaceuticals Inc (NASDAQ:INO), Mast Therapeutics Inc (NYSEMKT:MSTX ...share market updates (press release)Shares of Inovio Pharmaceuticals Inc (NASDAQ:INO) ended Monday session in green amid volatile trading. The shares closed up +0.60 points or 6.43% at $9.93 with 1.58 million shares getting traded. Post opening the session at $9.70, the shares hit an ...and more »
05/13/16 12:00 PMBroker Roundup For Mast Therapeutics, Inc. (MSTX) - Share Trading News - Broker Roundup For Mast Therapeutics, Inc. (MSTX)Share Trading News10/03/2013 – Cantor Fitzgerald began new coverage on Mast Therapeutics, Inc. giving the company a “buy” rating. The share price of Mast Therapeutics, Inc. (MSTX) was down -5.16% during the last trading session, with a day high of 0.33. 1460883 shares ...and more »
05/13/16 12:00 PMHC Stocks Outlines: Athersys Inc. (ATHX), Mast Therapeutics Inc (MSTX), Herbalife Ltd. (HLF) - share market updates (press release) - share market updates (press release)HC Stocks Outlines: Athersys Inc. (ATHX), Mast Therapeutics Inc (MSTX), Herbalife Ltd. (HLF)share market updates (press release)Shares of Athersys Inc. (NASDAQ:ATHX) ended Thursday session in red amid volatile trading. The shares closed down -0.06 points or -2.62% at $2.23 with 627,368.00 shares getting traded. Post opening the session at $2.30, the shares hit an intraday low ...
05/11/16 12:20 PMAnalysis EPS Report overview: Mast Therapeutics Inc (NYSEMKT:MSTX) - News Oracle - Analysis EPS Report overview: Mast Therapeutics Inc (NYSEMKT:MSTX)News OracleLast Trade: The Company rose 0.38% and finished at $0.31. The daily volume was measured at 1.66 million shares. The 52-week high of the share price is $0.60 and the 52-week low is $0.21. The company has a market cap of $61.35 million. Its latest ...and more »
05/09/16 12:32 PMHC Hot Stocks Judgment: IsoRay Inc. (ISR), Mast Therapeutics Inc (MSTX), Omeros Corporation (OMER) - share market updates (press release) - HC Hot Stocks Judgment: IsoRay Inc. (ISR), Mast Therapeutics Inc (MSTX), Omeros Corporation (OMER)share market updates (press release)Shares of IsoRay, Inc. (NYSEMKT:ISR) closed at $1.01 with 97,818 shares getting traded. Post opening the session at $1.02, the shares hit an intraday low of $1.01 and an intraday high of $1.05 and the price vacillated in this range throughout the day.
05/07/16 11:50 AMKeep an eye on Analyst Actions: Mast Therapeutics, Inc. (NYSEMKT:MSTX) , Cerus Corporation (NASDAQ:CERS) - Street Updates - Keep an eye on Analyst Actions: Mast Therapeutics, Inc. (NYSEMKT:MSTX) , Cerus Corporation (NASDAQ:CERS)Street UpdatesMast Therapeutics, Inc. (NYSEMKT:MSTX) decreased -0.627% or -0.002 points. The company traded volume of 1.37 million shares less than average volume of 1.73 million shares. It has the market value of $51.87M and its EPS ratio for the past year is ...
05/06/16 07:14 AMMast Therapeutics Reports First Quarter 2016 Financial Results And Recent Highlights - [at noodls] - SAN DIEGO, May 6, 2016 /PRNewswire/ -- Mast Therapeutics, Inc. (NYSE MKT: MSTX), a biopharmaceutical company developing novel, clinical-stage therapies for sickle cell disease and heart failure, today ...
05/04/16 11:51 AMTwo Healthcare stocks to Focus: Pfizer, Inc. (NYSE:PFE) , Mast Therapeutics, Inc. (NYSEMKT:MSTX) - Is stories - Two Healthcare stocks to Focus: Pfizer, Inc. (NYSE:PFE) , Mast Therapeutics, Inc. (NYSEMKT:MSTX)Is storiesPfizer, Inc. (NYSE:PFE) increased +2.74% to $33.70 while traded 71.53 million shares on 5/3/2016. The stock price negotiated for value between $33.25 to $33.97 in recent trading session. During the past 52 weeks, the stock's price witnessed a minimum ...
05/02/16 12:58 PMTraders Checklist Stocks: Mast Therapeutics, Inc. (NYSEMKT:MSTX) , Synta Pharmaceuticals Corp. (NASDAQ:SNTA) - Street Updates - Traders Checklist Stocks: Mast Therapeutics, Inc. (NYSEMKT:MSTX) , Synta Pharmaceuticals Corp. (NASDAQ:SNTA)Street UpdatesOn4/29/2016, shares of Mast Therapeutics, Inc. (NYSEMKT:MSTX) fell -1.8279% in trading session and finally closed at $0.2954. The company most recent volume stood at 1.16 million shares as compared to its average volume of 1.69 million shares.Mast Therapeutics Incorporated (NYSEMKT:MSTX) Sellers Covered 37.78% of Their ShortsThe PostHot Stocks: Boston Scientific Corporation (NYSE:BSX), Mast Therapeutics, Inc. (NYSEMKT:MSTX), Cross Country ...Benchmark Monitorall 3 news articles »
04/25/16 12:43 PMTrending Tickers: Intrexon Corporation (NYSE:XON), Mast Therapeutics, Inc. (NYSEMKT:MSTX), Yahoo! Inc. (NASDAQ ... - KC Register - Trending Tickers: Intrexon Corporation (NYSE:XON), Mast Therapeutics, Inc. (NYSEMKT:MSTX), Yahoo! Inc. (NASDAQ ...KC RegisterMast Therapeutics, Inc. (NYSEMKT:MSTX)'s stock had its “buy” rating reaffirmed by equities research analysts at Maxim Group in a research note issued on Tuesday,AnalystRatings.Net reports. They presently have a $5.00 price objective on the stock.and more »
04/25/16 12:43 PMTrending healthcare Stocks Update: Shire PLC (ADR) (SHPG), Mast Therapeutics Inc (MSTX) - News Oracle - Trending healthcare Stocks Update: Shire PLC (ADR) (SHPG), Mast Therapeutics Inc (MSTX)News OracleShire PLC (ADR) (NASDAQ:SHPG) surged 0.40% Friday and closed at $185.15. The company's market capitalization is at $36.48 billion with an average trading volume of 2.72 Million. The total number of Outstanding Shares Held by the company are 610.80 ...
04/25/16 12:43 PMMast Therapeutics, Inc. (MSTX) Latest Broker Coverage - Risers & Fallers - Mast Therapeutics, Inc. (MSTX) Latest Broker CoverageRisers & FallersA number of investment brokers have recently updated their price targets on shares of Mast Therapeutics, Inc. (MSTX). According to the latest broker reports outstanding on Monday 25th of April, 0 analysts have a rating of “strong buy”, 0 analysts “buy ...and more »
04/22/16 12:38 PMMast Therapeutics, Inc. (MSTX) Latest Broker Views - Risers & Fallers - Mast Therapeutics, Inc. (MSTX) Latest Broker ViewsRisers & FallersA number of investment brokers have recently updated their price targets on shares of Mast Therapeutics, Inc. (MSTX). According to the latest broker reports outstanding on Friday 22nd of April, 0 analysts have a rating of “strong buy”, 0 analysts “buy ...and more »
04/21/16 12:30 PMHealthcare Sector Stocks Alert: Tenet Healthcare Corp (THC), Mast Therapeutics Inc (MSTX) - News Oracle - Healthcare Sector Stocks Alert: Tenet Healthcare Corp (THC), Mast Therapeutics Inc (MSTX)News OracleTenet Healthcare Corp (NYSE:THC) surged 1.55% yesterday and closed at $32.06. The company's market capitalization is at $3.15 Billion with an average trading volume of 2.53 Million. The total number of Outstanding Shares Held by the company are 99.25 ...
04/20/16 12:28 PMStocks in the Spotlight: Brinker International, Inc. (EAT), Mast Therapeutics, Inc. (MSTX), Synta Pharmaceuticals ... - iStreetWire - Stocks in the Spotlight: Brinker International, Inc. (EAT), Mast Therapeutics, Inc. (MSTX), Synta Pharmaceuticals ...iStreetWireMast Therapeutics, Inc. (MSTX) continued its downward trend with the stock declining -6.57% or $-0.02 to close the day at $0.33 on light trading volume of 2.53M shares, compared to its three month average trading volume of 1.58M. The San Diego ...and more »
04/20/16 12:28 PMNotable Runners - Mast Therapeutics, (NYSEMKT:MSTX), Heron Therapeutics, (NASDAQ:HRTX) - Hot Stocks Point - Bidness ETCNotable Runners - Mast Therapeutics, (NYSEMKT:MSTX), Heron Therapeutics, (NASDAQ:HRTX)Hot Stocks PointMast Therapeutics Inc (NYSEMKT:MSTX) lost -6.57% and closed in the last trading session at $0.327. The company's price range for the trading day was $0.33 to $0.37. The 52-Week range of the stock is $0.21 – $0.60. The company's Market capitalization is ...What Analyst Recommend Regarding Stocks? Baxalta Incorporated (NYSE:BXLT), Mast Therapeutics, Inc. (NYSEMKT ...WsNews 4investorsall 35 news articles »
04/19/16 12:00 PMMaxim Analysts Bullish On Pioneering Biotech Stocks: Mast Therapeutics Inc (MSTX) and StemCells Inc (STEM) - Smarter Analyst - Maxim Analysts Bullish On Pioneering Biotech Stocks: Mast Therapeutics Inc (MSTX) and StemCells Inc (STEM)Smarter AnalystBoth Mast Therapeutics Inc (NYSEMKT:MSTX) and StemCells Inc (NASDAQ:STEM) are in deep waters where few other biotech giants tread. While Mast is working on a pioneering sickle cell disease treatment, StemCell is using breakthrough technology to ...Latest Analyst Ratings For Mast Therapeutics, Inc. (MSTX)Share Trading News2 Best Healthcare sector Stocks: Mast Therapeutics Inc (MSTX), 22nd Century Group Inc (XXII)News OracleMast Therapeutics Incorporated (NYSEMKT:MSTX) Short Interest Increased By 11.11%Franklin IndependentWsNews 4investorsall 5 news articles »
04/12/16 08:26 AMWill Mast Therapeutics (MSTX) Continue to Surge Higher? -
04/10/16 12:17 PMMast Therapeutics, Inc. (MSTX) Broker Price Targets For The Coming Week - Share Trading News - Mast Therapeutics, Inc. (MSTX) Broker Price Targets For The Coming WeekShare Trading NewsRecently some investment brokers have made changes to their outstanding price targets on shares of Mast Therapeutics, Inc. (MSTX). According to data from Reuters, 1 analyst has a rating of “buy”, 5 analysts “outperform”, 0 analysts “hold”, 0 analysts ...and more »
04/08/16 12:18 PMHealthcare Sector Companies for Investors: Mast Therapeutics Inc (MSTX), BioCryst Pharmaceuticals (BCRX) - News Oracle - Healthcare Sector Companies for Investors: Mast Therapeutics Inc (MSTX), BioCryst Pharmaceuticals (BCRX)News OracleMast Therapeutics Inc (NYSEMKT:MSTX) surged 2.10% yesterday and closed at $0.306. The company's market capitalization is at $61.48Million with an average trading volume of 1.35Million. The total number of Outstanding Shares Held by the company are ...Bvf Incil Lowers stake in Mast Therapeutics Inc (MSTX)The Sussex Pilotall 4 news articles »
04/06/16 10:25 AMFour Trending Stocks Investors Are Watching On Wednesday 4/6/2016 - [Accesswire] - MIAMI, FL / ACCESSWIRE / April 6, 2016 / Top Nasdaq Stocks is issuing a report on four stocks to watch. PSUN, COOL, UNXL, and MSTX have been added to our watch list today. Continue reading to find out ...
04/05/16 11:30 AMActive Runners in Thrust- Mast Therapeutics (NYSEMKT:MSTX), Intrexon (NYSE:XON), Frontier Communications ... - Seneca Globe - Active Runners in Thrust- Mast Therapeutics (NYSEMKT:MSTX), Intrexon (NYSE:XON), Frontier Communications ...Seneca GlobeStocks of Mast Therapeutics, Inc. (NYSEMKT:MSTX) shows upbeat performance increased 3.70% to trade at $0.28 in last session with shares volume of 1.65 Million. Mast Therapeutics, Inc. (MSTX) released that data from nonclinical studies of vepoloxamer, ...and more »
04/05/16 11:30 AMWill these Stocks Fall? ZIOPHARM Oncology Inc. (ZIOP), Mast Therapeutics Inc (MSTX) - News Oracle - News OracleWill these Stocks Fall? ZIOPHARM Oncology Inc. (ZIOP), Mast Therapeutics Inc (MSTX)News OracleZIOPHARM Oncology Inc. (NASDAQ:ZIOP) surged 3.94% yesterday and closed at $7.92. The company's market capitalization is at $1.07 Billion with an average trading volume of 2.91 Million. The total number of Outstanding Shares Held by the company are ...and more »
04/01/16 11:57 AMInsider Trades one should see: Mast Therapeutics (NYSEMKT:MSTX) - Beacon Chronicle - Insider Trades one should see: Mast Therapeutics (NYSEMKT:MSTX)Beacon ChronicleMast Therapeutics Inc (NYSEMKT:MSTX) reported gain of 4.72% and closed at $0.273 yesterday. The Company's Market capitalization stands at $56.27 Million with 192.84 Million of Outstanding Shares. The company traded 2.04 Million shares yesterday.Morning Alert: Mast Therapeutics, Inc. (NYSEMKT:MSTX), CorMedix, Inc. (NYSEMKT:CRMD), Steel Dynamics Inc ...Stock Transcriptall 2 news articles »
03/24/16 12:00 PMMast Therapeutics Incorporated (NYSEMKT:MSTX) Shorts Decreased by 64.63% After Short Covering - RiversideGazette.com - Mast Therapeutics Incorporated (NYSEMKT:MSTX) Shorts Decreased by 64.63% After Short CoveringRiversideGazette.comThe short interest to Mast Therapeutics Incorporated's float is 1.53%. The stock is down 1.60% or $0.004 after the news, hitting $0.247 per share. About 721,109 shares traded hands. Mast Therapeutics Inc (NYSEMKT:MSTX) has declined 46.81% since ...
03/23/16 10:42 AMStock's Ratings to Focus: Great Basin Scientific, Inc. (NASDAQ:GBSN) , Mast Therapeutics, Inc. (NYSEMKT:MSTX) - Street Updates - Street UpdatesStock's Ratings to Focus: Great Basin Scientific, Inc. (NASDAQ:GBSN) , Mast Therapeutics, Inc. (NYSEMKT:MSTX)Street UpdatesMast Therapeutics, Inc. (NYSEMKT:MSTX) showed bullish move with gain of +0.3529% after exchanging volume of 2.12 million shares in last trading session ended on 3/22/2016. The company recent traded volume was higher than its average volume of 1.54 ...
03/23/16 10:42 AMPrice Target Update: Mast Therapeutics (MSTX) - Everything HUDSON - Price Target Update: Mast Therapeutics (MSTX)Everything HUDSONThe 52-week high of the share price is $0.599 and the company has a market cap of $49 million. The 52-week low of the share price is at $0.2111 . Mast Therapeutics (NYSEMKT:MSTX) has received a short term rating of buy from experts at Zacks with a rank ...
03/14/16 10:59 AMMast reports 4Q loss - SAN DIEGO (AP) _ Mast Therapeutics Inc. (MSTX) on Monday reported a loss of $10.2 million in its fourth quarter. On a per-share basis, the San Diego-based company said it had a loss of 6 cents. The results fell short of Wall Street expectations.
03/14/16 10:59 AMMast Therapeutics : reports 4Q loss - SAN DIEGO (AP) _ Mast Therapeutics Inc. (MSTX) on Monday reported a loss of $10.2 million in its fourth quarter. On a per-share basis, the San Diego-based company said it had a loss of 6 cents. For the year, the company reported that its loss widened to $ ...
03/14/16 10:59 AMMast Therapeutics reports net loss of $10.2 million for fourth quarter 2015 - Mast Therapeutics, Inc. (NYSE MKT: MSTX), a biopharmaceutical company developing novel, clinical-stage therapies for sickle cell disease and heart failure, today reported financial results for the fourth quarter and year ended December 31, 2015.
03/14/16 07:21 AMMAST THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E -
03/14/16 07:00 AMMast Therapeutics Reports Fourth Quarter And Full Year 2015 Financial Results - [PR Newswire] - SAN DIEGO, March 14, 2016 /PRNewswire/ -- Mast Therapeutics, Inc. (NYSE MKT: MSTX), a biopharmaceutical company developing novel, clinical-stage therapies for sickle cell disease and heart failure, today ...
03/11/16 10:43 AMMast Therapeutics Incorporated (NYSEMKT:MSTX) Short Interest Increased By 7.65% - Business Standard Tribune - Mast Therapeutics Incorporated (NYSEMKT:MSTX) Short Interest Increased By 7.65%Business Standard TribuneThe short interest to Mast Therapeutics Incorporated's float is 3.89%. The stock is up 2.42% or $0.007 after the news, hitting $0.284 per share. About 185,950 shares traded hands. Mast Therapeutics Inc (NYSEMKT:MSTX) has declined 34.88% since August 5, ...
02/21/16 10:03 AMMast Therapeutics Incorporated (NYSEMKT:MSTX) Sellers Covered 6.59% of Their Shorts - Business Standard Tribune - Mast Therapeutics Incorporated (NYSEMKT:MSTX) Sellers Covered 6.59% of Their ShortsBusiness Standard TribuneThe short interest to Mast Therapeutics Incorporated's float is 3.62%. The stock decreased 3.50% or $0.01 on February 19, hitting $0.27. About 1.48 million shares traded hands. Mast Therapeutics Inc (NYSEMKT:MSTX) has declined 43.75% since July 16, ...
02/17/16 09:52 AMPrice Target Update On Mast Therapeutics, Inc. (MSTX) - Risers & Fallers - Price Target Update On Mast Therapeutics, Inc. (MSTX)Risers & FallersA number of investment brokers have recently updated their price targets on shares of Mast Therapeutics, Inc. (MSTX). According to the latest broker reports 1 analyst has a rating of “buy”, 5 analysts “outperform”, 0 analysts “hold”, 0 analysts ...
02/10/16 09:46 AMMast Therapeutics Announces Pricing Of Underwritten Public Offering - PR Newswire (press release) - Mast Therapeutics Announces Pricing Of Underwritten Public OfferingPR Newswire (press release)SAN DIEGO, Feb. 10, 2016 /PRNewswire/ -- Mast Therapeutics, Inc. (NYSE MKT: MSTX), a biopharmaceutical company developing novel, clinical-stage therapies for sickle cell disease and heart failure, today announced the pricing of an underwritten public ...Mast prices equity offering; shares off 40%Seeking AlphaActive Stocks Need to Consider: Mast Therapeutics (NYSEMKT:MSTX), Bank of New York Mellon (NYSE:BK ...Seneca GlobeToday's Hot List: The Walt Disney Company (NYSE:DIS), Mast Therapeutics, (NYSEMKT:MSTX), Tanger Factory Outlet ...Benchmark Monitorall 4 news articles »
02/01/16 08:21 AMMAST THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits -
01/26/16 10:53 AMMast Therapeutics, Inc. Analyst Rating Update - Market Briefing - Mast Therapeutics, Inc. Analyst Rating UpdateMarket BriefingMast Therapeutics, Inc. (NYSEMKT:MSTX) has received a buy rating for the short term, according to the latest rank of 2 from research firm, Zacks Investment Research. The company received an average rating of 1 from 4 analysts. 4 have rated it as a ...
01/25/16 09:26 AMCompany Shares of Mast Therapeutics, Inc. (NYSEMKT:MSTX) Rally 6.33% - Bull Report - Company Shares of Mast Therapeutics, Inc. (NYSEMKT:MSTX) Rally 6.33%Bull ReportShares of Mast Therapeutics, Inc. (NYSEMKT:MSTX) rose by 6.33% in the past week and 4.87% for the last 4 weeks. In the past week, the shares have outperformed the S&P 500 by 4.85% and the outperformance increases to 13.34% for the last 4 weeks.and more »
About Mast Therapeutics

No company description available

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: MSTX
  • CUSIP:
Key Metrics:
  • Previous Close: $0.47
  • 50 Day Moving Average: $0.373
  • 200 Day Moving Average: $0.345
  • P/E Ratio: N/A
  • P/E Growth: 0.000
  • Market Cap: $91.02M
  • Current Quarter EPS Consensus Estimate: $-0.240 EPS
Additional Links:
Mast Therapeutics (NASDAQ:MSTX) Chart for Tuesday, June, 28, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha